Viewing Study NCT00077493

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 1:23 AM
Ignite Modification Date: 2026-02-01 @ 6:59 PM
Study NCT ID: NCT00077493
Status: SUSPENDED
Last Update Posted: 2007-12-28
First Post: 2004-02-10
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: BL22 Immunotoxin In Treating Young Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia or Non-Hodgkin's Lymphoma
Sponsor: MedImmune LLC
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Leukemia View
None Lymphoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None recurrent childhood acute lymphoblastic leukemia View
None Burkitt lymphoma View
None recurrent childhood large cell lymphoma View
None recurrent childhood lymphoblastic lymphoma View
None childhood non-Hodgkin lymphoma View